Table 2.
- Baseline characteristics of the patients (N=201).
| Cardiovascular risk factors at baseline, n=201 | n (%) | ||
|---|---|---|---|
| Medical history | |||
| Hypertension | 109 (54.2) | ||
| Type-2 diabetes | 107 (53.2) | ||
| Ongoing CAD | 33 (16.4) | ||
| Family history of stroke or MI | 23 (11.4) | ||
| History of HF (class II and III) | 7 (3.5) | ||
| Lifestyle habits | |||
| Exercise less than once per month | 145 (75.1) | ||
| Current smoking | 64 (32.8) | ||
| Poor diet | 24 (17.3) | ||
| Body mass index categories, | |||
| n=179 | |||
| 18.5-25 kg/m 2 | 46 (25.7) | ||
| 25-30 kg/m 2 | 71 (39.7) | ||
| >30 kg/m 2 | 62 (34.6) | ||
| Blood laboratory tests | Mean ± SD | Median (Q1;Q3) | |
| ALT, in U/L * Creatinine, in mg/dL Total cholesterol, in mg/dL** HDL-C, in mg/dL Triglycerides, in mg/dL HbA1c, in mmol/mol*** |
115.7± 139.48 50.3±46.4 1.1±0.8 178.7±52.1 37.8±12.3 107.1±71.4 71.2±19.0 |
55 (27.0;146.0) 38 (27.0;61.0) 0.9 (0.8;1.2) 174.2 (142.3;210) 36.3 (29.0;43.7) 88.9 (51.8;141) 70 (55.0;83) |
|
| ALT: alanine aminotransferase, AST: aspartate aminotransferase, BMI: body mass index, CAD: coronary artery disease, HbA1c: glycated hemoglobin, HDL-C: high-density lipoprotein cholesterol, HF: heart failure, MI: myocardial infarction, SD: standard deviation, *Reference range for ALT: 4-36 U/L and for AST: 5-30 U/L22, **Reference values for total cholesterol: ≤ 190 mg/dL; LDL-C: ≤ 115 mg/dL; HDL-C: ≥40 mg/dL and Triglycerides: ≤150 mg/dL, 23 ***HbA1c levels between 39 and 47 mmol/mol indicate prediabetes and >47 mmol/mol indicate diabetes 24 | |||